نتایج جستجو برای: l1 cells

تعداد نتایج: 1409324  

Journal: :Biochemical and Biophysical Research Communications 2021

Cancer immunotherapy, especially treatment with monoclonal antibodies (mAbs) that block programmed cell death-1 (PD-1)/programmed death-ligand 1 (PD-L1) signaling, has attracted attention as a new therapeutic option for cancer. However, only limited number of patients have responded to this approach. In study, we searched compounds enhance the efficacy anti-PD-1 mAb using mixed lymphocyte react...

Journal: :Steroids 2016
Hung-Yun Lin Yu-Tang Chin André Wendindondé Nana Ya-Jung Shih Hsuan-Yu Lai Heng-Yuan Tang Matthew Leinung Shaker A. Mousa Paul J. Davis

The PD-1 (programmed death-1)/PD-L1 (PD-ligand 1) checkpoint is a critical regulator of activated T cell-cancer cell interactions, defending tumor cells against immune destruction. Nano-diamino-tetrac (NDAT; Nanotetrac) is an anticancer/anti-angiogenic agent targeted to the thyroid hormone-tetrac receptor on the extracellular domain of integrin αvβ3. NDAT inhibits the cancer cell PI3-K and MAPK...

Journal: :The Journal of Cell Biology 1995
M Ruppert S Aigner M Hubbe H Yagita P Altevogt

The L1 adhesion molecule is a member of the immunoglobulin superfamily shared by neural and immune cells. In the nervous system L1 can mediate cell binding by a homophilic mechanism. To analyze its function on leukocytes we studied whether L1 could interact with integrins. Here we demonstrate that VLA-5, an RGD-specific fibronectin receptor on a wide variety of cell types, can bind to murine L1...

Journal: Vaccine Research 2015
A Arashkia , H Barzegar , H Sharifi , K Azadmanesh , L Langroudi ,

Introduction: Cervical cancer is the second most common cancer in women worldwide and the role of human papillomavirus (HPV) has been proved in its etiology. The currentley available L1-capsid-protein-based vaccine is highly immunogenic and very high titers of serum antibodies can be obtained by its injection, but unfortunately it is restricted to only a few HPV genotypes and is relatively expe...

Journal: :Nucleic Acids Research 2006
Evan A. Farkash Gary D. Kao Shane R. Horman Eline T. Luning Prak

Long Interspersed Elements (LINE-1s, L1s) are the most active mobile elements in the human genome and account for a significant fraction of its mass. The propagation of L1 in the human genome requires disruption and repair of DNA at the site of integration. As Barbara McClintock first hypothesized, genotoxic stress may contribute to the mobilization of transposable elements, and conversely, ele...

Journal: :The Journal of Experimental Medicine 2006
Mary E. Keir Spencer C. Liang Indira Guleria Yvette E. Latchman Andi Qipo Lee A. Albacker Maria Koulmanda Gordon J. Freeman Mohamed H. Sayegh Arlene H. Sharpe

Programmed death 1 (PD-1), an inhibitory receptor expressed on activated lymphocytes, regulates tolerance and autoimmunity. PD-1 has two ligands: PD-1 ligand 1 (PD-L1), which is expressed broadly on hematopoietic and parenchymal cells, including pancreatic islet cells; and PD-L2, which is restricted to macrophages and dendritic cells. To investigate whether PD-L1 and PD-L2 have synergistic or u...

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 2003
Marcel Dihné Christian Bernreuther Mirjam Sibbe Werner Paulus Melitta Schachner

Adhesion molecules play important roles in the development and regeneration of the CNS and PNS. We found that the immunoglobulin superfamily recognition molecule L1 influences proliferation and differentiation of neural precursor cells. Substrate-coated L1 reduced proliferation of precursor cells in a dose-dependent manner and increased neuronal and decreased astrocytic differentiation when com...

2017
Wencheng Zhang Qingsong Pang Xiaodong Zhang Cihui Yan Qifeng Wang Jinsong Yang Shufei Yu Xiao Liu Yi Pan Zhiyong Yuan Ping Wang Zefen Xiao

Programmed death-ligand 1 (PD-L1) expression either indicates immune inhibitory status or concurrent immune response. Although the relationship between PD-L1 and clinical outcomes has been studied widely in recent years, its role in prognosis of esophageal squamous cell carcinoma (ESCC) remains unclear. Here, we assessed the significance of PD-L1 in ESCC and its association with epidermal growt...

Journal: :The Journal of clinical investigation 2016
Asim Saha Roddy S O'Connor Govindarajan Thangavelu Scott B Lovitch Durga Bhavani Dandamudi Caleph B Wilson Benjamin G Vincent Victor Tkachev Jan M Pawlicki Scott N Furlan Leslie S Kean Kazutoshi Aoyama Patricia A Taylor Angela Panoskaltsis-Mortari Rocio Foncea Parvathi Ranganathan Steven M Devine Joel S Burrill Lili Guo Catarina Sacristan Nathaniel W Snyder Ian A Blair Michael C Milone Michael L Dustin James L Riley David A Bernlohr William J Murphy Brian T Fife David H Munn Jeffrey S Miller Jonathan S Serody Gordon J Freeman Arlene H Sharpe Laurence A Turka Bruce R Blazar

Programmed death ligand-1 (PD-L1) interaction with PD-1 induces T cell exhaustion and is a therapeutic target to enhance immune responses against cancer and chronic infections. In murine bone marrow transplant models, PD-L1 expression on host target tissues reduces the incidence of graft-versus-host disease (GVHD). PD-L1 is also expressed on T cells; however, it is unclear whether PD-L1 on this...

2016
Antoni Ribas Siwen Hu-Lieskovan

Expression of the programmed death-1 (PD-1) ligand 1 (PD-L1) is used to select patients and analyze responses to anti-PD-1/L1 antibodies. The expression of PD-L1 is regulated in different ways, which leads to a different significance of its presence or absence. PD-L1 positivity may be a result of genetic events leading to constitutive PD-L1 expression on cancer cells or inducible PD-L1 expressi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید